Sampre Nutritions Hits 65 Back-to-Back Upper Circuits; Company Allots 5,50,000 Equity Shares on Preferential Basis

The stock price has locked in a 2% upper circuit on Monday as well. The company has strengthened its equity base and operational prospects with a series of strategic moves. The company recently allotted 5,50,000 equity shares on a preferential basis following the conversion of warrants, boosting its paid-up capital to ₹21.55 crore. 

Board Approval and Warrant Conversion Details

Sampre Nutritions Limited, a small-cap listed company, announced the allotment of 5,50,000 equity shares on a preferential basis following the conversion of warrants. Each share carries a face value of ₹10. With this issue, the company’s paid-up equity capital has increased to ₹21,55,68,550, up from ₹21,00,68,550.

The allotment was approved in a Board meeting. The warrants, allotted earlier on November 13, 2024, were converted at an exercise price of ₹60.50 per warrant, of which ₹45.375 per warrant (75% of the total) was payable at the time of conversion.

The total amount received by the company from this conversion stands at ₹2,49,56,250. Promoter Brahma Gurbani converted 5,00,000 warrants into equity shares, while public allottee Vishal Ratan Gurbani converted 50,000 warrants. Post-allotment, Brahma Gurbani’s holding rose from 8,87,416 shares (4.12%) to 13,87,416 shares (6.28%), while Vishal Ratan Gurbani’s stake increased from 7,505 shares (0.03%) to 57,505 shares (0.26%).

Outstanding Warrants

Following this issue, 2,90,000 warrants remain outstanding. These warrant holders retain the right to convert them into equity shares by May 13, 2026, on payment of the remaining 75% of the exercise price. The newly allotted equity shares will rank pari passu with the existing equity shares of the company.

New Manufacturing Agreement with Rama Exports

Sampre Nutritions Limited, a Small-Cap confectionery manufacturer, entered into a three-year manufacturing agreement with Rama Exports on August 19, 2025. Under this agreement, Sampre Nutritions will handle the manufacture, supply, quality assurance, and packaging of nutraceutical and food products under its brand specifications. Rama Exports will procure the finished goods at mutually agreed prices. The deal is projected to generate business worth ₹15 crore, strengthening Sampre Nutritions’ nutraceutical and food operations.

Sampre Nutritions Share Price Hit Back-to-Back Upper Circuit

Sampre Nutrition's share price is locked in the 2% upper circuit on Monday. The stock price has witnessed record breaking streak of hitting 65 upper circuits From its 52-week low of ₹20.90, the stock has delivered a return of 357%. The stock price hit 65 consecutive upper circuits.